Tuesday, August 13, 2019
Mastectomy for Ductal Carcinoma insitu, impact on patient Essay
Mastectomy for Ductal Carcinoma insitu, impact on patient - Essay Example In fact, DCIS accounts for approximately 20% of all new breast cancer and precancerous condition diagnoses (Clause Stowe & Carter 2001). With or without treatment, DCIS patients have a very high survival rate; and, for most women diagnosed with DCIS, it is not considered to be a life-threatening condition. Mastectomy is the preferred, and most effective, treatment option for DCIS patients (Katz et al. 2010). However, there is currently very little research regarding how patients are actually affected by choosing mastectomy to treat DCIS; and, since the number of new DCIS diagnoses is continuing to increase, much more research is needed. DCIS, also called intraductal carcinoma, is a condition whereby the cancer cells develop in the milk ducts of the breast and have not moved out of the duct into any of the surrounding tissue (National Institute of Health 2009). As mentioned above, there is disagreement as to whether or not DCIS should be called cancer; and, some experts often refer to it as "stage zero breast cancer" ( Harris & Morrow 2009). Even though DCIS itself is not considered to be harmful, it is a known risk factor for invasive breast cancer (Zuckerman 2009). While most DCIS patients do not develop invasive breast cancer, approximately two percent (2%) of DCIS cases show evidence of metastases and an even smaller percentage of cases do actually develop into invasive breast cancer (Cornfield et al. 2004). Certain biomarkers may help to identify whether DCIS patients are at high or low risk of developing invasive breast cancer; however, more research is necessary to make more accurate risk predictions (Welch et al. 2008). Currently, however, there is no way to determine or predict which DCIS cases will in fact develop into invasive breast cancer. This paper will try to determine the available information on the rationale for selecting this modality; explore literature regarding the physiological/biological basis of the treatment or how the treatment manage s the disease, critic the impact this treatment had on the individual and the nursesââ¬â¢ role in addressing this, and consider how the patientsââ¬â¢ experience could have been improved. Discussion Overview: Even without treatment, most women diagnosed with DCIS do not go on to develop invasive breast cancer. DCIS patients that do opt for treatment have surgical options, the most common being lumpectomy (with or without radiation therapy) and mastectomy. Lumpectomy followed by radiation therapy and mastectomy have the same high survival rate of 96% and above; however, mastectomy does have a slightly lower recurrence rate than lumpectomy with radiation which has a lower recurrence rate than lumpectomy alone (Holmberg et al. 2008; Hughes et al. 2009). Other factors have been found to affect DCIS recurrence rates
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.